Report Detail

Pharma & Healthcare Global and United States Anti-inflammatory Drugs Market Insights, Forecast to 2026

  • RnM2362993
  • |
  • 21 September, 2020
  • |
  • Global
  • |
  • 146 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Anti-inflammatory Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Anti-inflammatory Drugs market is segmented into
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Segment by Application, the Anti-inflammatory Drugs market is segmented into
Skin Rashes
Chronic Arthritis
Other

Regional and Country-level Analysis
The Anti-inflammatory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-inflammatory Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-inflammatory Drugs Market Share Analysis
Anti-inflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-inflammatory Drugs business, the date to enter into the Anti-inflammatory Drugs market, Anti-inflammatory Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Bayer
Novacap
Kopran Ltd.


1 Study Coverage

  • 1.1 Anti-inflammatory Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Anti-inflammatory Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type
    • 1.4.2 Aspirin
    • 1.4.3 Ibuprofen
    • 1.4.4 Naproxen
    • 1.4.5 Celecoxib
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application
    • 1.5.2 Skin Rashes
    • 1.5.3 Chronic Arthritis
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Anti-inflammatory Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Anti-inflammatory Drugs Revenue 2015-2026
    • 2.1.2 Global Anti-inflammatory Drugs Sales 2015-2026
  • 2.2 Global Anti-inflammatory Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Anti-inflammatory Drugs Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Anti-inflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Anti-inflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Anti-inflammatory Drugs Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Anti-inflammatory Drugs Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Anti-inflammatory Drugs Revenue Forecast by Region (2021-2026)

3 Global Anti-inflammatory Drugs Competitor Landscape by Players

  • 3.1 Global Top Anti-inflammatory Drugs Sales by Manufacturers
    • 3.1.1 Global Anti-inflammatory Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Anti-inflammatory Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Anti-inflammatory Drugs Manufacturers by Revenue
    • 3.2.1 Global Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Anti-inflammatory Drugs Revenue in 2019
    • 3.2.5 Global Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Anti-inflammatory Drugs Price by Manufacturers
  • 3.4 Global Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Anti-inflammatory Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Anti-inflammatory Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Anti-inflammatory Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Anti-inflammatory Drugs Revenue by Type (2015-2020)
    • 4.1.3 Anti-inflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Anti-inflammatory Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Anti-inflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Anti-inflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Anti-inflammatory Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Anti-inflammatory Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Anti-inflammatory Drugs Revenue by Application (2015-2020)
    • 5.1.3 Anti-inflammatory Drugs Price by Application (2015-2020)
  • 5.2 Anti-inflammatory Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Anti-inflammatory Drugs Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
    • 6.1.1 United States Anti-inflammatory Drugs Sales YoY Growth 2015-2026
    • 6.1.2 United States Anti-inflammatory Drugs Revenue YoY Growth 2015-2026
    • 6.1.3 United States Anti-inflammatory Drugs Market Share in Global Market 2015-2026
  • 6.2 United States Anti-inflammatory Drugs Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Anti-inflammatory Drugs Players by Sales (2015-2020)
    • 6.2.2 United States Top Anti-inflammatory Drugs Players by Revenue (2015-2020)
  • 6.3 United States Anti-inflammatory Drugs Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Anti-inflammatory Drugs Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Anti-inflammatory Drugs Price by Type (2015-2020)
  • 6.4 United States Anti-inflammatory Drugs Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Anti-inflammatory Drugs Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Anti-inflammatory Drugs Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Anti-inflammatory Drugs Price Forecast by Type (2021-2026)
  • 6.5 United States Anti-inflammatory Drugs Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Anti-inflammatory Drugs Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Anti-inflammatory Drugs Price by Application (2015-2020)
  • 6.6 United States Anti-inflammatory Drugs Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Anti-inflammatory Drugs Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Anti-inflammatory Drugs Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Anti-inflammatory Drugs Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
  • 7.2 North America Anti-inflammatory Drugs Market Facts & Figures by Country
    • 7.2.1 North America Anti-inflammatory Drugs Sales by Country (2015-2020)
    • 7.2.2 North America Anti-inflammatory Drugs Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
  • 8.2 Europe Anti-inflammatory Drugs Market Facts & Figures by Country
    • 8.2.1 Europe Anti-inflammatory Drugs Sales by Country
    • 8.2.2 Europe Anti-inflammatory Drugs Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Anti-inflammatory Drugs Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Anti-inflammatory Drugs Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
  • 10.2 Latin America Anti-inflammatory Drugs Market Facts & Figures by Country
    • 10.2.1 Latin America Anti-inflammatory Drugs Sales by Country
    • 10.2.2 Latin America Anti-inflammatory Drugs Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Anti-inflammatory Drugs Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Anti-inflammatory Drugs Sales by Country
    • 11.2.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Roche
    • 12.1.1 Roche Corporation Information
    • 12.1.2 Roche Description and Business Overview
    • 12.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Roche Anti-inflammatory Drugs Products Offered
    • 12.1.5 Roche Recent Development
  • 12.2 Abbott Laboratories
    • 12.2.1 Abbott Laboratories Corporation Information
    • 12.2.2 Abbott Laboratories Description and Business Overview
    • 12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Abbott Laboratories Anti-inflammatory Drugs Products Offered
    • 12.2.5 Abbott Laboratories Recent Development
  • 12.3 Johnson & Johnson
    • 12.3.1 Johnson & Johnson Corporation Information
    • 12.3.2 Johnson & Johnson Description and Business Overview
    • 12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Johnson & Johnson Anti-inflammatory Drugs Products Offered
    • 12.3.5 Johnson & Johnson Recent Development
  • 12.4 Merck & Co.
    • 12.4.1 Merck & Co. Corporation Information
    • 12.4.2 Merck & Co. Description and Business Overview
    • 12.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Merck & Co. Anti-inflammatory Drugs Products Offered
    • 12.4.5 Merck & Co. Recent Development
  • 12.5 Pfizer
    • 12.5.1 Pfizer Corporation Information
    • 12.5.2 Pfizer Description and Business Overview
    • 12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Pfizer Anti-inflammatory Drugs Products Offered
    • 12.5.5 Pfizer Recent Development
  • 12.6 Amgen
    • 12.6.1 Amgen Corporation Information
    • 12.6.2 Amgen Description and Business Overview
    • 12.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Amgen Anti-inflammatory Drugs Products Offered
    • 12.6.5 Amgen Recent Development
  • 12.7 Sanofi
    • 12.7.1 Sanofi Corporation Information
    • 12.7.2 Sanofi Description and Business Overview
    • 12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Sanofi Anti-inflammatory Drugs Products Offered
    • 12.7.5 Sanofi Recent Development
  • 12.8 Novartis
    • 12.8.1 Novartis Corporation Information
    • 12.8.2 Novartis Description and Business Overview
    • 12.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Novartis Anti-inflammatory Drugs Products Offered
    • 12.8.5 Novartis Recent Development
  • 12.9 Eli Lilly
    • 12.9.1 Eli Lilly Corporation Information
    • 12.9.2 Eli Lilly Description and Business Overview
    • 12.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Eli Lilly Anti-inflammatory Drugs Products Offered
    • 12.9.5 Eli Lilly Recent Development
  • 12.10 Amgen
    • 12.10.1 Amgen Corporation Information
    • 12.10.2 Amgen Description and Business Overview
    • 12.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Amgen Anti-inflammatory Drugs Products Offered
    • 12.10.5 Amgen Recent Development
  • 12.11 Roche
    • 12.11.1 Roche Corporation Information
    • 12.11.2 Roche Description and Business Overview
    • 12.11.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Roche Anti-inflammatory Drugs Products Offered
    • 12.11.5 Roche Recent Development
  • 12.12 Novacap
    • 12.12.1 Novacap Corporation Information
    • 12.12.2 Novacap Description and Business Overview
    • 12.12.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Novacap Products Offered
    • 12.12.5 Novacap Recent Development
  • 12.13 Kopran Ltd.
    • 12.13.1 Kopran Ltd. Corporation Information
    • 12.13.2 Kopran Ltd. Description and Business Overview
    • 12.13.3 Kopran Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Kopran Ltd. Products Offered
    • 12.13.5 Kopran Ltd. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Anti-inflammatory Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Anti-inflammatory Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Anti-inflammatory Drugs . Industry analysis & Market Report on Anti-inflammatory Drugs is a syndicated market report, published as Global and United States Anti-inflammatory Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-inflammatory Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,650.40
    5,475.60
    7,300.80
    613,782.00
    920,673.00
    1,227,564.00
    325,611.00
    488,416.50
    651,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report